UPTI_PIG
ID UPTI_PIG Reviewed; 122 AA.
AC Q29100;
DT 01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT 01-NOV-1996, sequence version 1.
DT 25-MAY-2022, entry version 89.
DE RecName: Full=Uterine plasmin/trypsin inhibitor;
DE Short=UPTI;
DE Flags: Precursor;
OS Sus scrofa (Pig).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Laurasiatheria; Artiodactyla; Suina; Suidae; Sus.
OX NCBI_TaxID=9823;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 30-56, AND
RP CHARACTERIZATION.
RC TISSUE=Conceptus membrane, and Uterus;
RX PubMed=7929061; DOI=10.1016/s0021-9258(19)51051-1;
RA Stallings-Mann M.L., Burke M.G., Trout W.E., Roberts R.M.;
RT "Purification, characterization, and cDNA cloning of a Kunitz-type
RT proteinase inhibitor secreted by the porcine uterus.";
RL J. Biol. Chem. 269:24090-24094(1994).
CC -!- FUNCTION: Inhibitor of plasmin and trypsin. Also has a weak affinity
CC for chymotrypsin. Could serve to neutralize the activities of one or
CC more serine proteinases generated by the proliferating trophoblast
CC during the formation of the noninvasive placenta.
CC -!- TISSUE SPECIFICITY: Expressed only in the uterus and the endometrium.
CC -!- DEVELOPMENTAL STAGE: Maximally expressed during pregnancy until day 30
CC after which levels decrease significantly.
CC -!- INDUCTION: By progesterone.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; L14282; AAA62425.1; -; mRNA.
DR PIR; A55115; A55115.
DR RefSeq; NP_999036.1; NM_213871.1.
DR AlphaFoldDB; Q29100; -.
DR SMR; Q29100; -.
DR STRING; 9823.ENSSSCP00000026254; -.
DR PRIDE; Q29100; -.
DR GeneID; 396887; -.
DR CTD; 396887; -.
DR OrthoDB; 1613899at2759; -.
DR Proteomes; UP000008227; Unplaced.
DR Proteomes; UP000314985; Unplaced.
DR GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR GO; GO:0004867; F:serine-type endopeptidase inhibitor activity; IBA:GO_Central.
DR CDD; cd00109; KU; 1.
DR Gene3D; 4.10.410.10; -; 1.
DR InterPro; IPR002223; Kunitz_BPTI.
DR InterPro; IPR036880; Kunitz_BPTI_sf.
DR InterPro; IPR020901; Prtase_inh_Kunz-CS.
DR Pfam; PF00014; Kunitz_BPTI; 1.
DR PRINTS; PR00759; BASICPTASE.
DR SMART; SM00131; KU; 1.
DR SUPFAM; SSF57362; SSF57362; 1.
DR PROSITE; PS00280; BPTI_KUNITZ_1; 1.
DR PROSITE; PS50279; BPTI_KUNITZ_2; 1.
PE 1: Evidence at protein level;
KW Direct protein sequencing; Disulfide bond; Protease inhibitor;
KW Reference proteome; Serine protease inhibitor; Signal.
FT SIGNAL 1..20
FT /evidence="ECO:0000255"
FT PROPEP 21..29
FT /evidence="ECO:0000269|PubMed:7929061"
FT /id="PRO_0000016881"
FT CHAIN 30..122
FT /note="Uterine plasmin/trypsin inhibitor"
FT /id="PRO_0000016882"
FT DOMAIN 38..88
FT /note="BPTI/Kunitz inhibitor"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00031"
FT SITE 48..49
FT /note="Reactive bond"
FT /evidence="ECO:0000250"
FT DISULFID 38..88
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00031"
FT DISULFID 47..71
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00031"
FT DISULFID 63..84
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00031"
FT CONFLICT 36
FT /note="G -> A (in Ref. 1; AA sequence)"
FT /evidence="ECO:0000305"
FT CONFLICT 48
FT /note="S -> R (in Ref. 1; AA sequence)"
FT /evidence="ECO:0000305"
FT CONFLICT 52
FT /note="V -> I (in Ref. 1; AA sequence)"
FT /evidence="ECO:0000305"
FT CONFLICT 54
FT /note="Y -> V (in Ref. 1; AA sequence)"
FT /evidence="ECO:0000305"
SQ SEQUENCE 122 AA; 13109 MW; B9BEFB3A6FB76CEC CRC64;
MSRLCLSAAL LLLLGALVAS TPGDEESSLV RAGPPGFCRE PPYTGPCSAH FVRYFYNATT
GLCQSFVYGG CRGKQNNFMD EKECLHTCDT CAKAQGKRGN CASEMLKSTR PQGWAVAAFQ
MG